ESR1 and breast cancer: The effect of aspirin on cancer progression in humans is also unclear with Marshall and co-workers documenting that long-term daily aspirin use was associated with an increased risk of estrogen receptor/progesterone receptor (ER/PR)-negative breast cancer but decreased risk of ER/PR-positive breast cancer60.